North America Botanical Extracts Market Trends and Insights
Consumer Preference for Clean-Label Products
Clean-label preferences have grown from a niche trend to a mainstream purchasing standard in packaged food and beverage categories. In North America, the botanical extracts market is experiencing rising demand for natural flavors, colors, and preservation systems. Major brands are speeding up reformulation efforts, replacing synthetic inputs with traceable botanical alternatives. This shift benefits suppliers offering integrated solutions, including raw material sourcing, extraction, and application support. As a result, the gap between standardized extracts and lower-grade commodity materials is widening. Sensient's 2026 expansion plan for natural color production reflects producers' confidence in the continued activity of this conversion cycle during the current planning period.Growth of the Personal Care and Cosmetics Sector
In North America, the botanical extracts market is witnessing a surge in the commercial value of documented botanical actives, driven by evolving regulations in the beauty and personal care sector. Suppliers are now mandated to bolster traceability, maintain comprehensive safety files, and implement stringent quality controls to align with premium brands. The MoCRA initiative has amplified FDA's oversight on cosmetic safety, facility registrations, and reporting of adverse events, complicating the defense of informal sourcing. In Canada, the framework governing natural and non-prescription health products underscores the significance of quality documentation, especially for products straddling the line between topical care and health claims. Consequently, suppliers boasting standardized actives and advanced delivery systems are finding themselves competing on performance rather than price. This shift is amplifying the demand for clinically validated plant ingredients in skincare and hair care throughout the region.Stringent Regulatory Compliance and Evolving Standards
As compliance requirements grow stricter across supplements, cosmetics, and pharmaceutical sectors, larger companies in North America's botanical extracts market manage the added costs and time pressures more effectively than smaller firms. The FDA requires manufacturers to ensure the safety and accurate labeling of dietary supplement ingredients, increasing the need for testing, documentation, and supplier control. In Canada, regulations emphasize licensing and product support for companies aiming to enter or expand. The challenges intensify when botanical extracts shift toward therapeutic applications, as proof standards become more demanding. This slows the scaling of some promising products and directs buyers to suppliers with stronger regulatory capabilities.Other drivers and restraints analyzed in the detailed report include:
- Technological Advancements in Extraction Methods
- Integration of Digitalization, AI, and Supply Chain Innovation
- Availability of Synthetic Substitute Products
Segment Analysis
In 2025, herbs commanded a 40.03% share of the source segment, solidifying their dominance in North America's botanical extracts market. Their prominence stems from their dual utility in food formulations and supplements. Furthermore, established contract farming for herbs like rosemary, sage, peppermint, and lavender ensures a more reliable supply. The U.S. supplement landscape, shaped by the DSHEA framework, dictates the commercial journey of herb-based actives and the pace of new formulations. This regulatory backdrop facilitates the large-scale commercialization of herbs, outpacing many less-established botanical categories in routine applications.Flowers are set to be the fastest-growing source category, with a projected CAGR of 10.13% from 2026 to 2031. Their ascent is fueled by premium fragrance demands, functional skincare, and nutraceutical applications that rely on their delicate aromatic and bioactive profiles. However, demand varies: while marigold and hibiscus cater to broader applications, jasmine and tuberose command the higher-margin fragrance segment. IFF's bioprospecting deal in Brazil in 2025, followed by cultivation efforts in Grasse in 2026, underscores the industry's push to fortify supply chains for unique plant and flower materials. Meanwhile, spices, leaves, and other sources contribute to the volume, but their future hinges more on crop location and the mix of applications.
Complete Report Scope:
- By Source
- Herbs
- Spices
- Flowers
- Leaves
- Others
- By Technology
- CO2 Extraction
- Solvent Extraction
- Steam Distillation
- Enfleurage
- Others
- By Application
- Food and Beverages
- Dietary Supplements and Functional Foods
- Pharmaceuticals
- Cosmetics and Personal Care
- Animal Nutrition
- By Country
- United States
- Canada
- Mexico
- Rest of North America
List of Companies Covered in this Report:
- Givaudan SA
- International Flavors & Fragrances Inc (IFF)
- Symrise AG
- Kerry Group plc
- Firmenich SA
- Kalsec Inc
- Sensient Technologies Corporation
- ADM (Archer Daniels Midland Company)
- Cargill Incorporated
- Ingredion Incorporated
- Naturex SA (part of Givaudan)
- Martin Bauer Group
- Indena SpA
- Sabinsa Corporation
- Bio-Botanica Inc
- Nutra Green Biotechnology Co, Ltd
- Nexira
- Döhler Group
- Frutarom Industries Ltd (now part of IFF)
- Nature's Sunshine Products, Inc
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Givaudan SA
- International Flavors & Fragrances Inc (IFF)
- Symrise AG
- Kerry Group plc
- Firmenich SA
- Kalsec Inc
- Sensient Technologies Corporation
- ADM (Archer Daniels Midland Company)
- Cargill Incorporated
- Ingredion Incorporated
- Naturex SA (part of Givaudan)
- Martin Bauer Group
- Indena SpA
- Sabinsa Corporation
- Bio-Botanica Inc
- Nutra Green Biotechnology Co, Ltd
- Nexira
- Döhler Group
- Frutarom Industries Ltd (now part of IFF)
- Nature's Sunshine Products, Inc

